Test ID: FXPB
Fragile X Syndrome, Molecular Analysis
Method Description
Describes how the test is performed and provides a method-specific reference
The (CGG)(n)-repeat number for normal, intermediate, and premutation alleles is determined by analyzing a PCR-amplified product by capillary electrophoresis (Celera). Additionally, confirmation of premutation and full mutation alleles and determination of methylation status are assessed by Southern blot analysis of PCR-amplified product from DNA that is treated with a methylation-sensitive restriction enzyme.(Wilson J, Pratt V, Phansalkar A, et al: Consensus Characterization of 16 FMR1 Reference Materials: A Consortium Study. J Mol Diagn 2008;10:2-12; Snow K, Doud L, Hagerman R, et al: Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 1993;53:1217-1228)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday, Wednesday; 10 a.m.


